학술논문

Rapamycin treatment for amyotrophic lateral sclerosis protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial)
Document Type
Article
Source
In: Medicine (United States). (Medicine (United States), 1 June 2018, 97(24))
Subject
Language
English
ISSN
15365964
00257974